Objectives We hypothesise that women with type 2 diabetes and hypertension are less likely than comparable men to receive renin–angiotensin system (RAS)-inhibiting antihypertensive treatment, ...
Mistakes, whether spoken or promised, are universal. The feeling of putting our foot in our mouth arises from a key executive function that our brain controls: stopping ourselves. However, the ...
From Santiago Ramón y Cajal’s hand came branches and whorls, spines and webs. Now-famous drawings by the neuroanatomist in the late 19th and early 20th centuries showed, for the first time, the ...
BEIJING, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...
1 Lab for Autonomic Neuroscience, Imaging and Cognition (LANIC), Department of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, Jena, Germany 2 Institute of Psychiatry of the ...
BOSTON--(BUSINESS WIRE)--DeepCure, a therapeutics company using AI to discover novel therapies for inflammation and immune diseases, announced today the discovery of potent, selective oral small ...
Reflections from the European Society of Cardiology (ESC) Congress 2024. The views and opinions expressed in this interview are solely those of the interviewee. The article was authored independently ...
As you may know, there are four main types of enzyme inhibition: noncompetitive, uncompetitive, competitive, and mixed inhibition mechanisms. The similarity in their names makes it difficult and ...
Basel, August 8, 2024 – Novartis today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta ® (iptacopan), a first-in-class complement inhibitor for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback